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Abstract
Background: Vesicoureteral reflux is thought to predispose to urinary tract infection and renal scarring, and ureteral
reimplantation in childhood remains the gold standard for its treatment. It has been reported that the risk of postrenal
failure during pregnancy is increased among women with Politano-Leadbetter ureteral reimplantation. In previous case
reports on patients with progressive hydronephrosis and renal failure during pregnancy after ureteral reimplantation,
percutaneous nephrostomy was always required, so there has been no information about the clinical management of
such patients by ureteral stenting. Here we report a patient with a history of bilateral ureteral reimplantation, in whom
severe hydronephrosis during pregnancy was managed with ureteral stents.
Case presentation: A primigravida with severe hydronephrosis was referred to us at 29 weeks of gestation. Bilateral
Politano-Leadbetter ureteral reimplantation had been performed at the age of 3 years. She was hospitalized
immediately, and bilateral ureteral stents were successfully inserted. Post-obstructive diuresis occurred after the
stents were placed. Urinary tract infection developed after removal of the urethral catheter 1 week later, but
responded to antibiotic therapy and catheter replacement. Labor was induced at 39 weeks of gestation, with
vaginal delivery of a healthy male infant. Both stents were found to have spontaneously migrated into the
urethra after delivery. Repeat stenting under spinal anesthesia was required to improve postpartum symptoms
of back pain and fever. Right distal ureteral obstruction persisted at 6 months after delivery and repeat
ureteral reimplantation is planned.
Conclusions: General obstetricians will not necessarily pay attention to a history of Politano-Leadbetter ureteral
reimplantation, but these patients should undergo careful monitoring of renal function and urinary tract morphology
during perinatal care. In the present case, ureteral stenting was effective for postrenal failure during pregnancy after
ureteral reimplantation. If ureteral stenting is selected, attention should be paid to post-obstructive diuresis, infection,
and stent migration.
Keywords: Ureteral stenting, Pregnancy, Ureteral reimplantation, Postrenal failure
Background
In patients with vesicoureteral reflux (VUR), retrograde
flow of urine from the bladder to the kidneys occurs due
to failure of the ureterovesical valve mechanism. VUR is
thought to predispose to urinary tract infection and
renal scarring, with management involving both surgical
correction and medical treatment. Ureteral reimplanta-
tion remains the gold standard, with common proce-
dures being the Politano-Leadbetter technique and the
Cohen technique.
Little information is available regarding the long-term
outcome of antireflux surgery. It has been reported that
women with a history of Politano-Leadbetter ureteral re-
implantation have an increased risk of postrenal failure
during pregnancy secondary to narrowing of the distal
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ureters, and all reported patients have required
nephrostomy to achieve a good obstetric outcome [1–4].
Here we report a woman with Politano-Leadbetter ur-
eteral reimplantation for VUR, in whom ureteral stent-
ing rather than nephrostomy was performed to
successfully manage severe hydronephrosis during preg-
nancy. The possible complications of ureteral stenting
are also described.
Case presentation
A 24-year-old primigravida presented to our hospital at
29 weeks of gestation. She had undergone bilateral ur-
eteral reimplantation by the Politano-Leadbetter tech-
nique at the age of 3 years for vesicoureteral reflux and
her postoperative course had been uneventful. However,
she had mild back pain at presentation, and abdominal
ultrasound revealed severe bilateral hydronephrosis.
Blood pressure was 120/80 mmHg and serum creatinine
was increased to 3.57 mg/dl. We diagnosed acute postre-
nal failure and hospitalized her immediately. A double-
pigtail ureteral stent (4.7 French) was placed into each
ureter by our senior urologist under ultrasound guidance
without using fluoroscopy.
Because daily urine output exceeded 6 L after ureteral
stenting, a urethral catheter was inserted and saline was
infused intravenously to prevent dehydration. Serum
creatinine rapidly decreased to 1.1 mg/dl and hydrone-
phrosis improved, so the urethral catheter was removed
7 days after ureteral stenting (Fig. 1). Subsequently, the
patient developed high fever and severe back pain. La-
boratory data and urine culture revealed evidence of py-
elonephritis, with a white blood cell count of 13.1 × 103/
μL and C-reactive protein of 11.34 mg/dl. Streptococcus
agalactiae was isolated from a urine specimen. Another
urethral catheter was inserted and ceftriaxone sodium
(2 g/day) was administered intravenously for 6 days,
after which her symptoms resolved. The urethral cath-
eter was removed again when urine output decreased.
Because there was no longer any clinical or laboratory
evidence of infection, she was discharged at 33 weeks of
gestation. Signs or symptoms of preterm labor, such as
shortening of the cervix or frequent uterine contrac-
tions, did not occur during hospitalization.
The patient was re-admitted at 39 weeks with gesta-
tional hypertension. Her systolic blood pressure was per-
sistently higher than 140 mmHg, although no
proteinuria was detected. After induction, she delivered
a boy weighing 3140 g. The Apgar score was 9 at 1 min
and 10 at 5 min.
She complained of back pain and fever on the day
after delivery, and it was found that both ureteral stents
had migrated into the urethra. Her symptoms subsided
after stents were placed into the bilateral ureters again
under spinal anesthesia. The patient was discharged two
weeks after delivery. An urologist removed both stents
at 6 months after delivery, but distal obstruction of the
right ureter was noted and a stent was inserted on the
right again. She is scheduled to undergo repeat bilateral
ureteral reimplantation.
Conclusions
A search of the English literature in PubMed using key
words including “vesicoureteral reflux”, “ureteral reim-
plantation”, and “pregnancy” identified seven women
with postrenal failure during pregnancy after undergoing
ureteral reimplantation in childhood. Six of the seven
women were managed by nephrostomy [Table 1].
Laverson et al. [3] reported a patient with bilateral
Fig. 1 Course of daily urine output and serum creatine after ureteral stenting
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ureteral stenting, in whom they could not place ureteral
catheters after stent removal due to edema at the
ureteral orifices. Cesarean section was performed at
30 weeks of gestation and the baby died. This patient
was treated with a right ureteral stent and left nephrost-
omy during her next pregnancy, resulting in delivery by
repeat cesarean section at term. It seems to be difficult
to insert ureteral catheters in these patients, although
ureteral stenting is not uncommon in pregnant women
[5]. In our patient, full term delivery was achieved after bi-
lateral placement of double-pigtail ureteral stents to con-
trol hydronephrosis secondary to Politano-Leadbetter
reimplantation for VUR.
However, several problems had to be overcome.
Post-obstructive diuresis is a dramatic increase of urine
output after the relief of urinary tract obstruction and
tends to be more severe in patients with chronic obstruc-
tion [6]. In our patient, diuresis began soon after ureteral
stenting. In 2 of the reported patients, post-obstructive di-
uresis occurred after percutaneous nephrostomy at
30 weeks of gestation and after cesarean delivery at
30 weeks [1, 3]. In our patient, renal failure may have
gradually developed from early pregnancy, although symp-
toms were only noted shortly before 29 weeks of gestation.
Post-obstructive diuresis usually persists until a euvolemic
state is reached and it is necessary to provide intravenous
saline to avoid dehydration, hypotension, and electrolyte
abnormalities, as was done in our patient.
One of the main complications associated with ur-
eteral stents is urinary tract infection, which often oc-
curs several weeks after stenting because of bacterial
colonization [7]. Our patient developed symptoms of
urinary tract infection accompanied by a strong inflam-
matory response and positive urine culture soon after
the removal of the urethral catheter at 1 week after ur-
eteral stent placement. Backflow of urine from the blad-
der into the kidneys may have occurred through the
stents and resulted in infection because urine output
was still high after removal of the urethral catheter, lead-
ing to rapid elevation of the intravesical pressure. Her
symptoms subsided and laboratory findings improved
after another urethral catheter was inserted and anti-
biotic therapy was provided. There was no recurrence of
symptoms when the urethral catheter was later removed
again, probably because urine output was much smaller.
Our experience with this patient suggests that the ureth-
ral catheter should only be removed after urine output is
close to normal.
Stent migration is an uncommon complication that is
related to inadequate positioning of the lip of the stent
[8]. In our patient, bilateral stent migration was noted
after delivery, although there were no problems during
pregnancy, suggesting that migration may be more likely
during delivery because of uterine contraction and invo-
lution. It is difficult to predict or prevent stent migra-
tion, so it is important to be aware of this possibility and
carefully observe the patient and the stent position.
According to previous reports, ureteral obstruction is
usually alleviated at least 4 weeks after delivery [1, 2]. It
may be relevant that physiological changes of pregnancy
revert to normal about 6 weeks after delivery. However,
ureteral obstruction was not relieved in some patients
[1–4] and surgery was required. The course of subse-
quent pregnancy also varies. The patient reported by
Laverson et al. did not receive surgical reimplantation
after her first pregnancy and hydronephrosis recurred
during the next pregnancy [3]. The first patient reported
by Mor et al. refused repeat reimplantation and hydro-
nephrosis recurred during her second pregnancy. Their
second patient received repeat ureteral reimplantation
by the Cohen method 3 years before her next pregnancy,
but she still required bilateral nephrostomy due to
hydronephrosis, hypertension, and azotemia at 29 weeks
of gestation. Their third patient had repeat reimplanta-
tion and subsequently experienced two uneventful preg-
nancies without urological complications. In their fourth





Treatment Perinatal outcome Reoperation after
delivery
Subsequent pregnancy
1 [3] 28 bilat ureteral stent failed ureteral
catheter replacement
C/S at 30 weeks
neonatal death
no rt ureteral catheter and lt
nephrostomy at 25 weeks
2 [2] 30 lt nephrostomy VD at full term no -
3 [1] 30 lt nephrostomy VD at 33 weeks no lt nephrostomy at 32 weeks
4 [1] 20 rt nephrostomy VD at 38 weeks yes bilat nephrostomy at 29 weeks
5 [1] 15 bilat nephrostomy VD at full term yes no treatment for 2 uneventful
pregnancies
6 [1] 30 rt nephrostomy VD at 35 weeks no conservative treatment
7 [4] 25 lt nephrostomy VD at 39 weeks yes -
8 present
case
29 bilat ureteral stent VD at 39 weeks scheduled for
reoperation
-
C/S cesarean section, VD vaginal delivery
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case, recurrent renal infection was a problem during the
first pregnancy and right percutaneous nephrostomy was
performed during the second pregnancy, but conserva-
tive treatment was sufficient for the third pregnancy [1].
In these patients, ureteral obstruction seems to be a
transient phenomenon during pregnancy and is impos-
sible to predict. Our patient is scheduled for reimplanta-
tion surgery before her next pregnancy. Even so, she
should be carefully monitored for hydronephrosis by ab-
dominal ultrasound and renal function tests, as well as
symptoms such as back pain, during her next pregnancy.
In conclusion, Politano-Leadbetter reimplantation for
VUR is associated with an increased risk of renal failure
during pregnancy due to distal ureteral obstruction.
Based on our experience, ureteral stenting is one of the
therapeutic options. If it is possible to insert stents, at-
tention should be paid to problems such as post-
obstructive diuresis, urinary tract infection, and stent
migration after delivery.
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